Akanda Corp. (AKAN) vs China SXT Pharmaceuticals, Inc. (SXTC)

Akanda Corp. and China SXT Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Akanda Corp. is the larger, with a market value of $2.2M against $2.0M — 1.1× the size. Across the 5 metrics below, Akanda Corp. leads on 4 and China SXT Pharmaceuticals, Inc. on 1.

Valuation

Metric AKAN SXTC Drug Manufacturers Specialty & Generic median
P/E — n/m 20.55
P/S — n/m 2.08
P/B n/m n/m 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m 2.66 12.22
EV/Sales n/m (5.94) 2.87
Earnings yield — (3,722.74%) (15.94%)
Free cash flow yield 0.00% 0.00% 0.00%

Profitability

Metric AKAN SXTC Drug Manufacturers Specialty & Generic median
Gross margin — 36.69% 53.51%
Operating margin — 0.00% 0.00%
Net margin — (255.16%) (2.45%)
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 0.00% (0.80%)
Return on assets 0.00% 0.00% (1.67%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AKAN SXTC Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (53.98%) 5.22%
EPS growth (last fiscal year) (139.63%) (162.25%) 42.91%
Revenue growth, 5-year CAGR 161.77% (24.94%) 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AKAN SXTC Drug Manufacturers Specialty & Generic median
Debt to equity (0.70) 0.03 0.04
Current ratio 0.22 7.94 2.41
Net debt to EBITDA (2.75) 3.86 1.01

Dividend

Metric AKAN SXTC Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric AKAN SXTC Drug Manufacturers Specialty & Generic median
Market cap 2.24m 2.02m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack